UPDATE: Morgan Stanley Downgrades Abbvie (ABBV) to Equalweight; Street Appreciates Hep-C and Humira Potential
Tweet Send to a Friend
(Updated - December 11, 2014 9:17 AM EST)
Morgan Stanley downgraded Abbvie (NYSE: ABBV) from Overweight to Equalweight with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley downgraded Abbvie (NYSE: ABBV) from Overweight to Equalweight with ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
